Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/2000
03/09/2000WO2000012535A2 Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof
03/09/2000WO2000012531A1 Ratc
03/09/2000WO2000012529A1 Sperm antigens associated with infertility
03/09/2000WO2000012516A1 Phosphohalohydrins, method for making same and uses
03/09/2000WO2000012497A2 Quinazoline derivatives as medicaments
03/09/2000WO2000012138A2 Cells expressing immunoregulatory molecules and uses therefor
03/09/2000WO2000012133A1 Neisseria spp. polypeptide, nucleic acid sequence and uses thereof
03/09/2000WO2000012132A1 Staphylococcal immunotherapeutics via donor selection and donor stimulation
03/09/2000WO2000012131A1 Multicomponent vaccines
03/09/2000WO2000012130A1 Rp105 agonists and antagonists
03/09/2000WO2000012129A2 Salmonella typhi vaccine compositions
03/09/2000WO2000012128A2 Recombinant subunit vaccine against flaviviral infection
03/09/2000WO2000012127A2 Dna cancer vaccine and methods for its use
03/09/2000WO2000012126A1 Autoantibody inhibitors
03/09/2000WO2000012125A1 Method for inducing a cell-mediated immune response and parenteral vaccine formulations therefor
03/09/2000WO2000012124A1 Oral vaccine compositions
03/09/2000WO2000012122A2 Low-molecular fragments of hyaluronic acid for the preparation of vaccines
03/09/2000WO2000012121A1 Method of dna vaccination
03/09/2000WO2000012113A2 Method of modulating memory effector t-cells using a cd2-binding agent, and compositions
03/09/2000WO2000012080A1 Diet composition and method of weight management
03/09/2000WO2000012066A1 Alginate capsules for use in the treatment of brain tumour
03/09/2000WO2000012065A1 Microparticulate composition
03/09/2000WO1999065518A3 Lt and ct in parenteral immunization methods against helicobacter infection
03/09/2000WO1999064570A9 Novel methods and interferon deficient substrates for the propagation of viruses
03/09/2000WO1999064068A9 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
03/09/2000WO1999063063A8 Cellular proteins which mediate herpesvirus entry
03/09/2000WO1999060017A3 Human tumour-derived polypeptide hormone phosphatonin
03/09/2000WO1999055873A3 Basb006 polynucleotide(s) and polypeptides from neisseria meningitis
03/09/2000WO1999053949A3 Combination of antigen pulsed apcs and interleukin 12 for tumor and viral therapy
03/09/2000DE4090565C2 Rekombinantes Herpesvirus-Pockenvirus-Vakzin A recombinant herpesvirus poxvirus vaccine
03/09/2000CA2777661A1 Multicomponent vaccines
03/09/2000CA2731995A1 Method for inducing a cell-mediated immune response and parenteral vaccine formulations therefor
03/09/2000CA2514899A1 Method of modulating memory effector t-cells and compositions
03/09/2000CA2342534A1 Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof
03/09/2000CA2342250A1 Quinazoline derivatives as medicaments
03/09/2000CA2341761A1 Novel polypeptide
03/09/2000CA2341755A1 Cells expressing immunoregulatory molecules and uses therefor
03/09/2000CA2341703A1 Salmonella typhi vaccine compositions
03/09/2000CA2341639A1 Superoxide dismutase as a vaccine antigen
03/09/2000CA2341596A1 Microparticulate composition
03/09/2000CA2341544A1 Method of dna vaccination
03/09/2000CA2341360A1 Nucleic acid and polypeptide p10 of a borna disease virus (bdv) and their use for diagnostic and immunization purposes
03/09/2000CA2341352A1 Oral vaccine compositions
03/09/2000CA2341311A1 Staphylococcus aureus genes and polypeptides
03/09/2000CA2341177A1 Staphylococcal immunotherapeutics via donor selection and donor stimulation
03/09/2000CA2341142A1 A novel method of diagnosing, monitoring, staging, imaging and treating various cancers
03/09/2000CA2340885A1 Protein domains in the hepatic glycogen-targetting subunit of protein phosphatase 1 and methods of making and using the same
03/09/2000CA2340865A1 High-affinity antibodies
03/09/2000CA2340794A1 Protein transport-associated molecules
03/09/2000CA2340788A1 Recombinant nonstructural protein subunit vaccine against flaviviral infection
03/09/2000CA2340596A1 Guanylate binding protein (gbp-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation
03/09/2000CA2340592A1 Phelix: a testis-specific protein expressed in cancer
03/09/2000CA2340462A1 Ehrlichia canis 120-kda immunodominant antigenic protein and gene
03/09/2000CA2340325A1 Alginate capsules for use in the treatment of brain tumour
03/09/2000CA2336961A1 Temperature-sensitive and cold-adapted human parainfluenza virus type 2 (hpiv-2) and vaccines based on such virus
03/09/2000CA2249657A1 Novel compounds
03/08/2000EP0984068A2 Sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
03/08/2000EP0984067A2 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
03/08/2000EP0984065A1 Modified treponema pallidum-derived antigen protein
03/08/2000EP0984023A1 Cell surface molecule mediating cell adhesion and signal transmission
03/08/2000EP0983767A1 Preventives or remedies for sensitized t cell-related diseases containing il-6 antagonists as the active ingredient
03/08/2000EP0983361A1 Bacterial pheromones and uses therefor
03/08/2000EP0983358A1 New human dp1 homolog
03/08/2000EP0983357A1 Modulators of tissue regeneration
03/08/2000EP0983356A1 Smad2 phosphorylation and interaction with smad4
03/08/2000EP0983354A2 Neurotrophic factor receptors
03/08/2000EP0983353A1 Methods and compositions for diagnosis and treatment of cancer
03/08/2000EP0983345A1 Methods and compositions for making dendritic cells from expanded populations of monocytes and for activating t cells
03/08/2000EP0983342A1 Culture medium with yeast or soy bean extract as aminoacid source and no protein complexes of animal origin
03/08/2000EP0983303A1 Method for the production of non-immunogenic proteins
03/08/2000EP0983298A1 Method of recovering shiga-like toxins and vaccines comprising inactivated shiga-like toxin
03/08/2000EP0983293A1 Fadd-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same
03/08/2000EP0983289A1 Oligonucleotide adjuvant
03/08/2000EP0983286A1 Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
03/08/2000EP0983272A1 A new class of benzoporphyrin derivative photoactive compounds
03/08/2000EP0983089A1 Therapeutic or prophylactic use of fibronectin-binding protein i (sfbi) as adjuvant
03/08/2000EP0983088A1 Immunopotentiating composition
03/08/2000EP0983087A1 Multivalent vaccine composition with mixed carrier
03/08/2000EP0983086A1 pH-SENSITIVE LIPOSOMES AND OTHER TYPES OF ENCAPSULATED VACCINES CONTAINING IMMUNOMODULATORS, AND METHODS FOR MAKING AND USING SAME
03/08/2000EP0983081A1 Transmucosal induction of tolerance to parenterally administered non-autologous polypeptides
03/08/2000EP0983078A1 SIALOADHESIN FAMILY 4 cDNA
03/08/2000EP0983074A2 Non-myeloablative tolerogenic treatment
03/08/2000EP0672136B1 Polypeptides, derived from endonexin 2, having hepatitis b virus receptor activity and their use in diagnostic and pharmaceutical compositions
03/08/2000EP0671947B1 Compositions for eliciting cytotoxic t-lymphocyte responses against viruses
03/08/2000EP0656062B1 Dorsal tissue affecting factor and compositions
03/08/2000CN1246867A Helicobacter pylori live vaccine
03/08/2000CN1246800A Infectious bursits vaccine
03/08/2000CN1246799A Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
03/07/2000US6034298 The vaccine is administered through the consumption of the edible plant as food, preferably in the form of a fruit or vegetable juice which can be taken orally.
03/07/2000US6034223 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereof
03/07/2000US6034219 Human macrophage antigen
03/07/2000US6034218 Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer
03/07/2000US6034214 Glu at its n terminus, tyr at its c terminus, and pro as its fourth amino acid
03/07/2000US6034063 Human phosphatidylinositol transfer protein gamma
03/07/2000US6033904 Recombinant swinepox virus
03/07/2000US6033886 Recombinant infectious non-segmented negative strand RNA virus
03/07/2000US6033877 Peptide expression and delivery system
03/07/2000US6033876 The antibodies may be used for diagnosis, or conjugated to a toxin to produce an immunotoxin.
03/07/2000US6033845 Specific diagnostic for feline infectious peritonitis antibodies
03/07/2000US6033844 Porcine reproduction respiratory syndrome diagnostic
1 ... 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 ... 1823